ABBV vs EUDAW · P/E 81, rev $61.16B vs rev $9.8M
AbbVie Inc (ABBV) versus EUDA Health Holdings Limited (EUDAW) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
EUDA Health Holdings Limited (EUDAW) common stock listed on US.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported EUDAW revenue for 2022-12-31 was $9.8M. Net income was -$24.9M. Revenue was down 6.7% from 2021-12-31 to 2022-12-31. EUDAW currently screens at market cap $0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. EUDAW currently screens at market cap $0.
Not investment advice. Open the ABBV and EUDAW stock pages for the full models.
Not investment advice.